A comprehensive view of Vials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Gilead resubmits application to FDA for approval of long-acting injectable HIV drug lenacapavir after FDA refused authorization in February due to drug’s compatibility with borosilicate glass vial; Gilead now using aluminosilicate glass vial for drug

Schott invests €40M to double production capacity of Fiolax borosilicate glass tubing at Mainz, Germany, facility to meet increasing global demand; investment creates 100 jobs to make tubing used to make vials, ampoules, cartridges, syringes

Fresenius Kabi introduces injectable PEMEtrexed in US to treat adult patients with non-squamous, non-small cell lung cancer and malignant pleural mesothelioma; drug is generic equivalent to Alimta, is available in four presentations in single-dose vials

Jubilant gets US$146.6M contract from US HHS to double injectables filling capacity to meet demand for COVID-19 treatments; company spending US$193M total to add high-speed injectable fill line with 400 vial-per-minute capacity to be completed by 2025

Packaging is creating bottlenecks in producing injectable drugs, as the industry lacks capacity to make and fill enough vials in the face of high volumes of COVID-19 vaccine production; however, auto-injector syringes are growing in popularity: GlobalData

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count